Medical Research News

RSS

Blood sugar levels link decision making to metabolic cues

Would you choose to receive a small amount of money today or a larger sum next month? We know that it is worth it to wait longer for a larger reward, but sometimes the temptation for the smaller, immediate reward becomes too great and we simply cannot resist it. Selecting the immediate reward is known as "future discounting" and often suggests a lack of self-control.

27 Jan 2010

Researchers join in a three-year project to pursue novel applications of HPC in radiotherapy

Researchers from the San Diego Supercomputer Center (SDSC) at UC San Diego have joined forces with the Department of Radiation Oncology in the university's School of Medicine, its Department of Mathematics, and the Lawrence Livermore National Laboratory (LLNL) in a three-year, $1.5 million project to pursue novel applications of high-performance computing (HPC) in radiotherapy.

27 Jan 2010

Exactech to fund more than $100,000 in research and residency enhancement grants through OREF's CDP

Exactech Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has committed more than $100,000 to fund research and residency enhancement grants and contribute to post-graduate fellowship grants through OREF’s Clinician Development Program (CDP).

27 Jan 2010

Kyoto University implements Isilon IQ for eliminating storage issues in diagnostic imaging research

Isilon® Systems today announced that Kyoto University's Department of Diagnostic Imaging and Nuclear Medicine has implemented Isilon's scale-out NAS for a new collaboration project focused on identifying new technologies and enhanced functionality in diagnostic imaging. With Isilon IQ, the Department has unified ultrasonic tomography, retinal tomography and MRI image data into a single, highly scalable, high performance, shared pool of storage to accelerate time-to-results for its mission-critical research.

27 Jan 2010

Health News Digest features Sunridge International's patented 'PNT' procedure

Sunridge International's patented "PNT" procedure was the topic of discussion in one of Health News Digest's recent articles published on January 24, 2010.

27 Jan 2010

Cees Veerman committee recommends continuation of TI Pharma in its present form

Top Institute Pharma (TI Pharma) enables unique public-private collaborations that are extremely valuable for pharmaceutical research in the Netherlands. This can be read in the Midterm Review (MTR) of the Top Institute, which was published today. In the report, an independent committee chaired by Cees Veerman concludes that TI Pharma is well on its way to achieving the objectives that were determined at the time of its establishment. The institute addresses issues with marked social relevance, attracts international investments and has brought forth a group of quality researchers.

27 Jan 2010

Burnham renamed to honor T. Denny Sanford's support

Burnham Institute for Medical Research (Burnham) announced today that philanthropist T. Denny Sanford has pledged $50 million to support and further expand and accelerate the Institute's leading-edge medical research. To honor Sanford, Burnham, has been renamed the Sanford-Burnham Medical Research Institute. This is the second gift Sanford has made to Burnham. In 2007, he directed $20 million through Sanford Health to create the Sanford Children's Health Research Center at Burnham.

27 Jan 2010

Women with higher blood levels of PBDEs take longer to become pregnant, say researchers

Women with higher blood levels of PBDEs, a type of flame retardant commonly found in household consumer products, took longer to become pregnant compared with women who have lower PBDE levels, according to a new study by researchers at the University of California, Berkeley.

27 Jan 2010

Scott & White conducts DBS research for Parkinson's patients

At Scott & White Memorial Hospital, a multi-disciplinary team of neurosurgeons, neurologists, neurophysiologist, neuropsychologists and a movement disorders specialist are offering hope to some Parkinson's patients with a treatment called Deep Brain Stimulation (DBS). DBS involves placing a thin wire that carries electrical currents deep within the brain on Parkinson's patients who are no longer benefitting from medications, and have significant uncontrollable body movements called dyskinesia. Scott & White is also performing research into the effects of DBS on the non-motor symptoms of Parkinson's disease including "drenching sweats," bladder dysfunction, depression, hallucination, anxiety, and dementia as well as intestinal disorders, loss of sense of smell, and sleep disturbances.

27 Jan 2010

Testing DBS for treating severe long-term depression

Bewernick and colleagues administered DBS treatment in ten patients with severe long-term depression who had not responded to multiple other antidepressant treatments, including psychotherapy, drug treatments and electroconvulsive treatment. After one year of DBS, all patients showed some improvement, and half of them experienced significant improvement in their symptoms of depression, astonishing considering they had not responded to any prior antidepressant treatment. In addition, the patients showed reduced ratings of anxiety and had only minor side effects. Importantly, none of their overall brain functioning was impaired by the DBS treatment.

27 Jan 2010

Texas to invest $4.5 mn in cancer research at UT Health Science Center

Texas plans to invest $3 billion in cancer research over the next 10 years and six scientists at The University of Texas Health Science Center at Houston are among the first to receive grants.The researchers, whose grants total $4.5 million, are working to protect girls from cervical cancer, to interrupt tumor growth at the molecular level and to develop a new approach for the treatment of colon cancer, among other cutting-edge projects.

27 Jan 2010

NTNU: 40% of two-year-olds report allergy-related disorders

Allergies and asthma are a continuing health problem in most developed countries, but just how do these ailments develop over the course of a childhood? In a population-based study designed to help answer this question, researchers at the Norwegian University of Science and Technology (NTNU) found that 40 per cent - or two of five -- of nearly 5,000 two-year-olds had at least one reported allergy-related disorder. The most common symptom was wheezing, which was reported in 26 per cent of all children in the study, says Ingeborg Smidesang, a PhD candidate in the university's Faculty of Medicine, and the primary author of the study.

25 Jan 2010

Self-treatment for back pain: Sensory motor learning

Many people with back pain do not know what is causing it and they do not receive effective treatment, but learning to move in a more integrated way makes a big difference, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

25 Jan 2010

Reproductive coercion and partner violence increase risk of unintended pregnancy

Young women and teenage girls often face efforts by male partners to sabotage birth control or coerce pregnancy - including damaging condoms and destroying contraceptives - and these efforts, defined as "reproductive coercion," frequently are associated with physical or sexual violence, a study by a team of researchers led by UC Davis has found.

25 Jan 2010

Dermatological nuisance caused by toilet seats making a comeback in pediatricians' offices

Considered a dermatological nuisance that was long gone, skin irritations caused by toilet seats appear to be making a comeback in pediatricians' offices, according to research led by Johns Hopkins Children's Center investigator Bernard Cohen, M.D.

25 Jan 2010

Canadian conference on managing legal & business risks in clinical trials

The nature of clinical trials is constantly changing in the ever-more globalized and adapting market. In this increasingly-scrutinized industry, it is important to maintain a transparent process, to appropriately manage risks and to avoid abuses, in order to get a piece of this multi-billion dollar industry. How? By effectively managing the legal and business risks!

23 Jan 2010

Study: Warburg effect promotes rapid cell proliferation and tumor growth

A team of scientists led by Professor Adrian Krainer, Ph.D., of Cold Spring Harbor Laboratory has discovered molecular factors in cancer cells that boost the production of an enzyme that helps alter the cells' glucose metabolism. The altered metabolic state, called the Warburg effect, promotes extremely rapid cell proliferation and tumor growth. Adrian Krainer, Ph.D.

23 Jan 2010

Pfizer's global R&D facilities to deploy ChemAxon's Markush platform

ChemAxon - a leading provider of cheminformatics software for the life sciences industry has entered into agreement with Pfizer to provide its Markush searching and structure enumeration functionality for global development and deployment within Pfizer's global R&D facilities.

23 Jan 2010

PhRMA funds a two-year research initiative to evaluate the safety and benefits of existing drugs

The Pink Sheet recently reported that the Pharmaceutical Research and Manufacturers of America (PhRMA) and individual drug firms, through the Foundation for the National Institutes of Health, are funding a two-year public/private research initiative to evaluate the safety and benefits of drugs that are currently on the market.

23 Jan 2010

Thomas S. Kilduff named a Fellow of the AAAS

SRI International, an independent nonprofit research and development institute, announced today that Thomas S. Kilduff, Ph.D., director of SRI International's Center for Neuroscience, has been named a Fellow of the American Association for the Advancement of Science (AAAS).

22 Jan 2010